🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07149597
Starting soon Observational

Clinical Validation Study on the Imaging Efficacy of Mobile 4D CBCT Technology for Peripheral Pulmonary Lesions

NCT07149597 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Chest Hospital
Phase
Observational
Started
2025-09-01
Last updated
2025-09-08

Condition(s) studied

Peripheral Pulmonary Lesions (PPLs)

Investigational drug(s) / intervention(s)

Mobile CBCT Three-Dimensional Scanning

Mobile CBCT Three-Dimensional Scanning: Mobile CBCT Three-Dimensional Scanning

Study summary

The purpose of this study is to evaluate the clinical value of mobile 4D CBCT technology in the diagnosis and treatment of peripheral pulmonary lesions and to validate its intraoperative dynamic three-dimensional CT imaging capability.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age \>18 years old. 2. Patients whose chest CT scans indicate the presence of peripheral pulmonary lesions and require further diagnosis via transbronchial lung biopsy (TBLB). 3. Lesion size: 8 mm \< longest diameter of lesion ≤ 50 mm. 4. Understands the study and has provided signed informed consent. Exclusion Criteria: 1. Contraindications to bronchoscopy are present. 2. Severe cardiopulmonary dysfunction or other conditions that may increase surgical risk. 3. The investigator considers that the patient has other conditions which make them unsuitable for participation in this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Chest Hospital Shanghai China

More Shanghai Chest Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07149597 on ClinicalTrials.gov ↗ ← All trials in China